NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE Amex: SNT) today announced that preclinical data for the Company’s lead drug candidate, SNS-01, will be presented on May 20, 2010 at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting being held at the Marriott Wardman Park Hotel in Washington, D.C. from May 17 to 22.
